☀️SuryAInvestrade
Home / Research / TSCO
Stock Thesis

TSCO: Stock thesis & analysis

As of 2026-08-15

📁 From our research archive: this thesis was generated on 2026-08-15 and may not reflect our current view. See the latest research →

TSCO is flagged as an orphan: reported ROE of ~40% and reasonable P/E (18.7x) look attractive on the surface, but P/FCF near 181x and FCF margin of 0.66% signal that free cash flow generation is far weaker than earnings quality implies, and D/E above 240% adds balance-sheet fragility. Smart-money confirmation is minimal (2 funds, persistence of only 1 quarter, no cluster) — well below Tier C/D thresholds — despite strong recent insider buying from the CEO and a director, which is a positive but insufficient counterweight. With composite quality score of 34/100 and combined score of 10/100, and no explicit business justification here for why institutional ownership remains so thin, this defaults to PASS per the orphan rubric.

Catalysts to watch

  • Continued insider buying could signal management confidence ahead of next earnings
  • Analyst initiations (8 in 30 days, mixed Buy/Neutral) may resolve into clearer consensus direction
  • Next quarterly filing will clarify whether FCF margin improves from current depressed level

Key risks

  • Free cash flow margin of 0.66% versus P/FCF of ~181x implies valuation is disconnected from actual cash generation
  • Debt/Equity above 240% leaves limited balance-sheet flexibility in a downturn
  • Minimal institutional fund ownership (2 funds, low persistence) despite headline profitability metrics
  • Recent 8-K officer/director change adds near-term governance uncertainty
  • Late-cycle credit conditions (HY OAS complacency) warrant caution on leveraged consumer-cyclical names

What would change the view

  • Stock breaks below $30.00
  • FCF margin remains under 1% for two consecutive quarters, confirming cash conversion weakness
  • D/E rises above 275% without a corresponding improvement in interest coverage

More AI stock thesis reports

Browse all public research →

Get these calls by email, free →
Already subscribed? Unlock this device →
Not financial advice. This is the published output of an AI-driven, human-in-the-loop research process on a paper (simulated) account: informational only, not personalized investment advice, and not a solicitation to buy or sell any security. Past performance does not guarantee future results. Do your own research and trade at your own discretion in your own account. See the full disclaimer, terms & privacy.